Intra-individual variation of GH-dependent markers in athletes: Comparison of population based and individual thresholds for detection of GH abuse in sports

Journal of Pharmaceutical and Biomedical Analysis

Volumn 84, Issue , 2013, Pages 201-208

  Kniess, Astrid ^a   Ziegler, Eckart ^b   Thieme, Detlef ^a   Müller, R Klaus ^a  

^a Institute of Doping Analysis and Sports Biochemistry   (Germany)

^b Investigating Physician   (Germany)

Author keywords

Biomarker; Doping; Growth hormone; Insulin like growth factor I (IGF I); N terminal propeptide of type III procollagen (PIIINP); Sport

Indexed keywords

BIOCHEMICAL MARKER; GROWTH HORMONE; PROCOLLAGEN; SOMATOMEDIN C;

ADULT; ARTICLE; ATHLETE; BLOOD SAMPLING; COMPARATIVE STUDY; DISCRIMINANT ANALYSIS; EXERCISE; FEMALE; FOOTBALL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ROWING; SPORT; TRAINING; VOLLEYBALL;

BIOMARKER; DOPING; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I (IGF-I); N-TERMINAL PROPEPTIDE OF TYPE III PROCOLLAGEN (PIIINP); SPORT;

ADOLESCENT; ADULT; ATHLETES; BIOLOGICAL MARKERS; DOPING IN SPORTS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INDIVIDUALITY; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; SPORTS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84880353515     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.06.008     Document Type: Article

References (23)

1. Hartman M.L., Iranmanesh A., Thorner M.O., Veldhuis J.D. Evaluation of pulsatile patterns of growth hormone release in man. Am. J. Hum. Biol. 1993, 5:603-614.
2. Wu Z., Bidlingmaier M., Dall R., Strasburger C.J. Detection of doping with human growth hormone. Lancet 1999, 353:895.
3. Bidlingmaier M., Suhr J., Ernst A., Wu Z., Keller A., Strasburger C.J. High-sensitive chemoluminescence immunoassays for detection of growth hormone doping in sports. Clin. Chem. 2009, 55:445-453.
4. Keller A., Wu Z., Kratzsch J., Keller E., Blum W.F., Kniess A., Preis R., Teichert J., Strasburger C.J., Bidlingmaier M. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur. J. Endocrinol. 2007, 156:647-653.
5. Dall R., Longobardi S., Ehrenborg C., Keay N., Rosen T., Jorgensen J.O.L., Cunoe R.C., Boroujerdi M.A., Cittadini A., Napoli R., Christiansen J.S., Bengtsson B.-A., Sacca L., Baxter R.C., Basset E.E., Sönksen P.H. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J. Clin. Endocrinol. Metab. 2000, 85:4193-4200.
6. Longobardi S., Keay N., Ehrenborg C., Cittadini A., Rosen T., Dall R., Boroujerdi M.A., Bassett E.E., Healy M.-L., Pentecost C., Wallace J.D., Powrie J., Jorgensen J.O., Sacca L. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J. Clin. Endocrinol. Metab. 2000, 85:1505-1512.
7. Wallace J.D., Cuneo R.C., Lundberg P.A., Rosén T., Jørgensen J.O., Longobardi S., Keay N., Sacca L., Christiansen J.S., Bengtsson B.A., Sönksen P.H. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J. Clin. Endocrinol. Metab. 2000, 85:124-133.
8. Wallace J.D., Cuneo R.C., Baxter R., Orskov H., Keay N., Pentecost C., Dall R., Rosén T., Jørgensen J.O., Cittadini A., Longobardi S., Sacca L., Christiansen J.S., Bengtsson B.A., Sönksen P.H. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J. Clin. Endocrinol. Metab. 1999, 84:3591-3601.
9. Kniess A., Ziegler E., Kratzsch J., Thieme D., Müller R.K. Potential parameters for the detection of hGH doping. Anal. Bioanal. Chem. 2003, 376:696-700.
10. Nelson A.E., Meinhardt U., Hansen J.L., Walker I.H., Stone G., Howe C.J., Leung K.C., Seibel M.J., Baxter R.C., Handelsman D.J., Kazlauskas R., Ho K.K. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J. Clin. Endocrinol. Metab. 2008, 93:2213-2222.
11. Ehrnborg C., Lange K.H., Dall R., Christiansen J.S., Lundberg P.A., Baxter R.C., Boroujerdi M.A., Bengtsson B.A., Healey M.L., Pentecost C., Longobardi S., Napoli R., Rosén T. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J. Clin. Endocrinol. Metab. 2003, 88:394-401.
12. Sartorio A., Jubeau M., Agosti F., Marazzi N., Rigamonti A., Müller E.E., Maffiuletti N.A. A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes. J. Endocrinol. Invest. 2006, 29:237-243.
13. Abellan R., Ventura R., Pichini S., Di Giovannandrea R., Bellver M., Olive R., Pacifici R., Pascual J.A., Zuccaro P., Segura J. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide. Int. J. Sports Med. 2006, 27:976-983.
14. Erotokritou-Mulligan I., Bassett E.E., Bartlett C., Cowan D., McHugh C., Seah R., Curtis B., Wells V., Harrison K., Sönksen P.H., Holt R.I. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 2008, 93:2760-2763.
15. Nelson A.E., Howe C.J., Nguyen T.V., Leung K.-C., Trout G.J., Seibel M.J., Baxter R.C., Handelsman D.J., Kazlauskas R., Ho K.K. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. J. Clin. Endocrinol. Metab. 2006, 91:4424-4432.
16. Healy M.-L., Gibney R.J., Bassett E., Ehrnborg C., Pentecost C., Rosen T., Cittadini A., Baxter R.C., Sönksen P.H. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J. Clin. Endocrinol. Metab. 2005, 90:641-649.
17. Nelson A.E., Ho K.K.Y. Demographic factors influencing the GH system: implications for the detection of GH doping in sport. Growth Horm. IGF Res. 2009, 19:327-332.
18. Erotokritou-Mulligan I., Bassett E.E., Cowan D.A., Bartlett C., McHugh C., Sönksen P.H., Holt R.I.G. Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse. Clin. Endicrinol. 2009, 70:161-168.
19. Powrie J.K., Bassett E.E., Rosen T., Jørgensen J.O., Napoli R., Sacca L., Christiansen J.S., Bengtsson B.A., Sönksen P.H. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 2007, 17. 220-206.
20. Erotokritou-Mulligan I., Bassett E.E., Knieß A., Sönksen P.H., Holt R.I. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets. Growth Horm. IGF Res. 2007, 17:416-423.
21. Nguyen T.V., Nelson A.E., Howe C.J., Seibel M.J., Baxter R.C., Handelsman D.J., Kazlauskas R., Ho K.K. Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin. Chem. 2008, 54:1268-1276.
22. Erotokritou-Mulligan I., Bassett E.E., Cowan D.A., Bartlett C., Milward P., Sartorio A., Sönksen P.H., Holt R.I.G. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin. Endicrinol. 2010, 72:520-526.
23. Erotokritou-Mulligan I., Guha N., Stow M., Bassett E.E., Bartlett C., Cowan D.A., Sönksen P.H., Holt R.I.G. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays. Growth Horm. IGF Res. 2012, 22:53-58.